TRIM29 and prostate adenocarcinoma: Furthermore, it is most likely that TRIM29 could regulate expression of ZNF750 and KRT5 in other tumors, as TRIM29 expression positively correlated with the expression of ZNF750 and KRT5 significantly in 18 tumor types, such as BLCA, CESC, HNSC, LUSC, PRAD, and SKCM.